Royalty Pharma Reports Second Quarter 2025 Results
NEW YORK, NY, August 6, 2025 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.
Earnings
Royalty Pharma published press releases by date and/or category
Royalty Pharma Declares Third Quarter 2025 Dividend
NEW YORK, NY, July 18, 2025 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share.
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
NEW YORK, NY, July 16, 2025 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2025 financial results on Wednesday, August 6, 2025 before the U.S. financial markets open.
Royalty Pharma Reports First Quarter 2025 Results
NEW YORK, NY, May 8th, 2025 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.
Royalty Pharma Declares Second Quarter 2025 Dividend
NEW YORK, NY, April 21, 2025 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ordinary share.
Royalty Pharma To Announce First Quarter 2025 Financial Results On May 8, 2025
NEW YORK, NY, April 17, 2025 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 before the U.S. financial markets open.
Royalty Pharma Reports Q4 and Full Year 2024 Results
NEW YORK, NY, February 11, 2025 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter and full year 2024 and introduced full year 2025 guidance for Portfolio Receipts.
Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
NEW YORK, NY, January 28, 2025 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2024 financial results on Tuesday, February 11, 2025 before the U.S. financial markets open.
Royalty Pharma Announces Dividend Increase
NEW YORK, NY, January 9, 2025 – Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ordinary share, reflecting a 5% increase in the company’s quarterly dividend over the previous quarter’s dividend.
Royalty Pharma Reports Third Quarter 2024 Results
NEW YORK, NY, November 6, 2024 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2024 and raised full year 2024 guidance for Portfolio Receipts.
